Integrating bulk, single-cell, and spatial transcriptomics to identify and functionally validate novel targets to enhance immunotherapy in NSCLC
Authors:
Open Access
- 16 April 2025
- journal article
- research article
- Published by Springer Nature in npj Precision Oncology
- Vol. 9 (1) , 1-22
Abstract
Programmed cell deaths (PCDs) are crucial for tumor progression. By analyzing 18 PCDs, we generated a robust multigene signature, Combined Cell Death Index (CCDI), comprising necroptosis and autophagy genes for non-small cell lung cancer (NSCLC). The CCDI accurately stratified patients by survival prognosis and predicted immunotherapy responses. We validated CCDI and prioritized CCDI genes using five single-cell RNA sequencing and two spatial transcriptomics datasets. CCDI positively correlates with tumor malignancy, invasiveness, and immunotherapy resistance. Four necroptosis genes (PTGES3, MYO6, CCT6A, and CTSH) may affect cancer cell evolution. In vitro, CTSH overexpression or PTGES3 knockdown inhibited NSCLC cell proliferation and migration while inducing necroptosis with necrosome formation. Moreover, we observed diminished CTSH, heightened PTGES3, and low necroptosis activity in 12 pairs of NSCLC tumors and normal tissues. CTSH overexpression or PTGES3 knockdown induced necroptosis and improved anti-PD1 therapy efficiency in syngeneic cancer mouse models. These findings indicate necroptosis genes as potential therapeutic targets in cancer treatments.Keywords
Funding Information
- Nn10 project of Harbin medical university cancer hospital (Nn102024-05)
- National Natural Science Foundation of China (82072985, 82172786)
- Heilongjiang Province Innovation Base Award Project (JD2023SJ03)
- The Climbing Program of Harbin Medical University Cancer Hospital (PDYS2024-02)
- the National Cancer Center Climbing Fund of China (NCC201908B06)
- Heilongjiang Provincial Natural Science Foundation of China (ZD2024H003)
- Beijing Xisike Clinical Oncology Foundation (Y-2024AZ(EGFR)MS-0187)
This publication has 109 references indexed in Scilit:
- Prognostic impact and immunotherapeutic implications of NETosis-related prognostic model in clear cell renal cell carcinomaJournal of Cancer Research and Clinical Oncology, 2024
- Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinomaCancer Cell, 2023
- MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cellsCancer Cell, 2022
- Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinomaCancer Immunology, Immunotherapy, 2021
- Targeting immunogenic cell death in cancerMolecular Oncology, 2020
- A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndromeJournal of Molecular Medicine, 2020
- Contributions and prognostic values of m6A RNA methylation regulators in non‐small‐cell lung cancerJournal of Cellular Physiology, 2020
- ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer ImmunotherapyAdvanced Science, 2020
- Anoikis: an emerging hallmark in health and diseasesThe Journal of Pathology, 2011
- A Nonapoptotic Cell Death Process, Entosis, that Occurs by Cell-in-Cell InvasionCell, 2007